Pscilly

Reviews of EB-003 – Novel neuroplastogen designed to engage 5-HT2A and 5-HT1B receptors

No reviews yet. Share the first one.

EB-003 – Novel neuroplastogen designed to engage 5-HT2A and 5-HT1B receptors by Enveric Biosciences

EB-003 is investigational and is being developed for difficult-to-treat mental health disorders, including PTSD, treatment-resistant depression, and generalized anxiety disorder. It is in preclinical development, with IND-enabling work underway and…

Guides about EB-003 – Novel neuroplastogen designed to engage 5-HT2A and 5-HT1B receptors

Related news

More from Enveric Biosciences